Humana’s pharmacy business is highly competitive and subjects it to regulations and supply chain risks in addition to those the company faces with its core health benefits businesses. Changes in the prescription drug industry pricing benchmarks may adversely affect Humana’s financial ...
Wheatley told investors Tuesday that the Trump proposal to force Medicare plans to pass on negotiated drug discounts to consumers at the pharmacy counter would result in lower prices for its members using brand names drugs, but there will be trade-offs. Standard prescription drug plans will likely...